HeartSciences Inc. (HSCS) News
Track canonical SquawkNews coverage tagged to HSCS, HeartSciences Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 13 indexed stories across 5 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
HeartSciences posts $3.2M FQ1 2027 net loss; no meaningful revenue
HeartSciences reported a $3.2 million net loss for its fiscal first quarter ended July 31, 2026, with no meaningful revenue. Loss from operations was $2.9 million, including a $0.3 million inventory reserve tied to its w
EARNINGS | Sep 15, 2026, 09:15 PM UTC
H
HeartSciences Inc. (NASDAQ:HSCS) Posts Wider FQ1 Loss; Fortitude Deal on Track
HeartSciences reported FQ1 2027 net loss of $3.2M vs $2.1M and no meaningful revenue. The Fortitude merger is expected to close in Q4 2026, subject to conditions.Material DetailsContext by AI AnalystThis is early-stage c
EARNINGS | Sep 15, 2026, 01:31 PM UTC
L
HeartSciences Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update
Proposed business combination with Fortitude, a vertically-integrated digital asset mining platform anchored in Zcash, continues to progress, with closing expected in Q4 calendar 2026Commercial effort concentrated on the
EARNINGS | Sep 15, 2026, 01:31 PM UTC
L
HeartSciences Had a Shareholders' Deficit of $2M at July 31 >HSCS
HeartSciences Had a Shareholders' Deficit of $2M at July 31 >HSCS
NEWS | Sep 15, 2026, 01:28 PM UTC
L
HeartSciences 1Q Loss $3.2M >HSCS
HeartSciences 1Q Loss $3.2M >HSCS
NEWS | Sep 15, 2026, 01:28 PM UTC
L
HeartSciences Inc. Q1 2027: Revenue $2.1K, Net loss $(3.17M), EPS $(0.86) — 10-Q Summary
HeartSciences Inc. reported results for the quarter ended July 31, 2026 (Q1 2027 fiscal), posting revenue of $2.1K and a net loss of $(3.17M), or diluted EPS of $(0.86). Revenue was essentially flat year—over—year versus
EARNINGS | Sep 14, 2026, 08:22 PM UTC
H
HSCS: Net loss widened to $3.2M as revenue stalled and merger completion remains uncertain
Revenue remained minimal at $2,000 for the quarter ended July 31, 2026, with a net loss of $3.2 million and a working capital deficit of $4.8 million. Focus shifted to MyoVista Insights™, while a merger with Fortitude Mi
EARNINGS | Sep 14, 2026, 08:18 PM UTC
L
HSCS Q1’26 EPS estimate (0.72) USD ahead of Sept. 10 results
HeartSciences Inc. (HSCS) is set to announce Q1’26 results on September 10, with earnings expected at 8:00 AM ET (12:00 PM UTC). Q1’26 revenue estimate is 0 USD; EPS estimate is (0.72) USD.
EARNINGS | Sep 09, 2026, 11:00 AM UTC
L
HeartSciences set to report Q1’26 results Sept. 10
HSCS (HeartSciences Inc.) is set to announce Q1’26 results on September 10, with expected disclosure at 8:00 AM ET. Q1’26 revenue estimate is 0 USD and EPS is anticipated at (0.72) USD.
EARNINGS | Sep 03, 2026, 11:00 AM UTC
M
12 Health Care Stocks Move
Twelve health care stocks are moving in Tuesday's intraday session, with Aditxt and Atlantic International leading the gainers and Trinity Biotech and Tenon Medical leading the losers
EQUITY | Jun 23, 2026, 05:09 PM UTC